The severe acute respiratory syndrome coronavirus

Details for Australian Patent Application No. 2004230485 (hide)

Owner Novartis Vaccines and Diagnostics, Inc.

Inventors Valiante, Nicholas; Song, Hyun Chul; Gregersen, Jens-Peter; Houghton, Michael; Masignani, Vega; Han, Jang; Chien, David; Klenk, Hans Dieter; Donnelly, John J.; Rappuoli, Rino; Polo, John; Seo, Mi Young; Stadler, Konrad; Weiner, Amy

Agent FB Rice

Pub. Number AU-B-2004230485

PCT Pub. Number WO2004/092360

Priority 60/465,273 23.04.03 US; 60/510,781 11.10.03 US; 60/463,983 17.04.03 US; 60/462,465 11.04.03 US; 60/473,144 22.05.03 US; 60/464,838 22.04.03 US; 60/463,668 16.04.03 US; 60/462,418 12.04.03 US; 60/529,464 11.12.03 US; 60/560,757 07.04.04 US; 60/464,899 22.04.03 US; 60/495,024 14.08.03 US; 60/465,535 24.04.03 US; 60/462,748 13.04.03 US; 60/536,177 12.01.04 US; 60/463,109 14.04.03 US; 60/468,312 05.05.03 US; 60/463,971 18.04.03 US; 60/462,218 10.04.03 US; 60/463,460 15.04.03 US; 60/505,652 23.09.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 22 January 2009

International Classifications

C07K 14/165 (2006.01) Peptides having more than 20 amino acids

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/215 (2006.01) Medicinal preparations containing antigens or antibodies - Coronaviridae, e.g. avian infectious bronchitis virus

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 7/06 (2006.01) Viruses, e.g. bacteriophages

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/092360 Priority application(s): WO2004/092360

11 September 2008 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

22 January 2009 Application Accepted

  Published as AU-B-2004230485

21 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230489-Plant cells and plants with increased tolerance to environmental stress

2004230483-Sample element for use in material analysis